NCT00294320View on ClinicalTrials.gov

Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Actinic Keratosis
Interventions
DRUG

Aldara (Imiquimod)

250mg of Imiquimod cream for application once daily 3 times per week.

OTHER

Vehicle cream

250mg vehicle cream for application once daily 3 times per week.

Trial Locations (1)

Unknown

Hopital L'Archet 2, Nice

All Listed Sponsors
lead

MEDA Pharma GmbH & Co. KG

INDUSTRY

NCT00294320 - Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions | Biotech Hunter | Biotech Hunter